Prognostic impact of persistent postoperative neutrophil-to-lymphocyte ratio elevation 1 year after colorectal cancer surgery - Report - MDSpire

Prognostic impact of persistent postoperative neutrophil-to-lymphocyte ratio elevation 1 year after colorectal cancer surgery

  • By

  • David Ortíz-López

  • Joaquín Marchena-Gómez

  • Yurena Sosa-Quesada

  • Manuel Artiles-Armas

  • Beatriz Arencibia-Pérez

  • Julia Gil-García

  • Eva Nogués-Ramía

  • Cristina Roque-Castellano

  • June 25, 2025

  • 0 min

Share

Long-term Prognostic Significance of Elevated Neutrophil-to-Lymphocyte Ratio After CRC Surgery

Overview

This study evaluated the prognostic impact of elevated neutrophil-to-lymphocyte ratio (NLR) one year after curative colorectal cancer surgery in 935 patients. Persistently high NLR postoperatively was associated with poorer long-term survival, independent of tumor stage and other clinical factors.

Background

Colorectal cancer (CRC) remains a leading cause of cancer-related death worldwide, with significant years of potential life lost. Traditional prognostic factors include tumor stage and serum tumor markers such as CEA and CA 19.9. Increasing evidence links systemic inflammation, measured by markers like the neutrophil-to-lymphocyte ratio (NLR), to CRC progression and survival outcomes. While preoperative NLR has been studied extensively, the evolution and prognostic significance of NLR after curative surgery are less well understood.

Data Highlights

ParameterValue/Description
Study population935 patients undergoing elective curative CRC surgery (2015-2022)
Follow-upBlood tests including NLR at 1 year post-surgery
NLR cutoff3.3 (Youden index)
Inclusion criteriaSurvival ≥1 year post-surgery, complete blood count available
Exclusion criteriaPalliative or urgent surgery, incomplete follow-up

Key Findings

  • Elevated NLR (>3.3) one year after surgery was independently associated with worse long-term survival in CRC patients.
  • Patients with persistently high NLR postoperatively had poorer prognosis regardless of tumor stage or adjuvant therapy.
  • NLR values can change postoperatively; some patients with normal preoperative NLR developed elevated NLR at 1 year, which also correlated with poorer outcomes.
  • Systemic inflammation as measured by NLR reflects ongoing tumor biology or host response beyond initial surgery.
  • Inclusion of postoperative NLR in follow-up may improve risk stratification and guide surveillance intensity.

Clinical Implications

Monitoring NLR at one year post colorectal cancer surgery provides valuable prognostic information beyond traditional staging. Persistently elevated NLR identifies patients at higher risk of recurrence or mortality who may benefit from closer surveillance or additional therapeutic interventions. Incorporating NLR into routine postoperative follow-up could enhance personalized patient management.

Conclusion

Persistent elevation of neutrophil-to-lymphocyte ratio one year after curative colorectal cancer surgery is a significant predictor of poor long-term survival. Postoperative inflammatory status should be considered in prognostic assessment and follow-up planning.

References

  1. Siegel et al. 2020 -- Colorectal cancer statistics
  2. Arnold et al. 2019 -- Years of potential life lost due to CRC
  3. AJCC 8th Edition 2017 -- Cancer Staging Manual
  4. Smith et al. 2018 -- Systemic inflammation and CRC prognosis
  5. Jones et al. 2021 -- Neutrophil-to-lymphocyte ratio in CRC

Original Source(s)

Related Content